{
    "startDate": "2019-01-01",
    "endDate": "2019-12-31",
    "year": "2019",
    "quarter": "FY",
    "symbol": "IONS",
    "data": {
        "bs": [
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 683287000
            },
            {
                "label": "Short-term investments",
                "concept": "AvailableForSaleSecuritiesDebtSecuritiesCurrent",
                "unit": "usd",
                "value": 1816257000
            },
            {
                "label": "Contracts receivable",
                "concept": "ContractWithCustomerAssetNetCurrent",
                "unit": "usd",
                "value": 63034000
            },
            {
                "label": "Inventories",
                "concept": "InventoryNet",
                "unit": "usd",
                "value": 18180000
            },
            {
                "label": "Other current assets",
                "concept": "OtherAssetsCurrent",
                "unit": "usd",
                "value": 139839000
            },
            {
                "label": "Total current assets",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 2720597000
            },
            {
                "label": "Property, plant and equipment, net",
                "concept": "PropertyPlantAndEquipmentNet",
                "unit": "usd",
                "value": 153651000
            },
            {
                "label": "Patents, net",
                "concept": "FiniteLivedIntangibleAssetsNet",
                "unit": "usd",
                "value": 25674000
            },
            {
                "label": "Long-term deferred tax assets",
                "concept": "DeferredIncomeTaxAssetsNet",
                "unit": "usd",
                "value": 305557000
            },
            {
                "label": "OtherAssetsNoncurrent",
                "concept": "OtherAssetsNoncurrent",
                "unit": "usd",
                "value": 27633000
            },
            {
                "label": "Amortization of patents",
                "concept": "Assets",
                "unit": "usd",
                "value": 3233112000
            },
            {
                "label": "Accounts payable",
                "concept": "AccountsPayableCurrent",
                "unit": "usd",
                "value": 16067000
            },
            {
                "label": "Accrued compensation",
                "concept": "EmployeeRelatedLiabilitiesCurrent",
                "unit": "usd",
                "value": 37357000
            },
            {
                "label": "Accrued liabilities",
                "concept": "AccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 66769000
            },
            {
                "label": "Income taxes payable",
                "concept": "AccruedIncomeTaxesCurrent",
                "unit": "usd",
                "value": 32514000
            },
            {
                "label": "LongTermDebtAndCapitalLeaseObligationsCurrent",
                "concept": "LongTermDebtAndCapitalLeaseObligationsCurrent",
                "unit": "usd",
                "value": 2026000
            },
            {
                "label": "Current portion of deferred contract revenue",
                "concept": "ContractWithCustomerLiabilityCurrent",
                "unit": "usd",
                "value": 118272000
            },
            {
                "label": "Accrued liabilities",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 273005000
            },
            {
                "label": "Long-term deferred contract revenue",
                "concept": "ContractWithCustomerLiabilityNoncurrent",
                "unit": "usd",
                "value": 490060000
            },
            {
                "label": "Long-term mortgage debt",
                "concept": "LongTermLoansFromBank",
                "unit": "usd",
                "value": 59913000
            },
            {
                "label": "Accrued liabilities",
                "concept": "Liabilities",
                "unit": "usd",
                "value": 1548565000
            },
            {
                "label": "Common stock, $0.001 par value; 300,000,000 shares authorized, 140,339,615 and 137,928,828 shares issued and outstanding at December 31, 2019 and December 31, 2018, respectively",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 140000
            },
            {
                "label": "Additional paid-in capital",
                "concept": "AdditionalPaidInCapitalCommonStock",
                "unit": "usd",
                "value": 2203778000
            },
            {
                "label": "Accumulated other comprehensive loss",
                "concept": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
                "unit": "usd",
                "value": -25290000
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -707534000
            },
            {
                "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": 1471094000
            },
            {
                "label": "Income (loss) before income tax benefit (expense)",
                "concept": "MinorityInterest",
                "unit": "usd",
                "value": 213453000
            },
            {
                "label": "Total stockholders' equity",
                "concept": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 1684547000
            },
            {
                "label": "LIABILITIES AND STOCKHOLDERS' EQUITY",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 3233112000
            }
        ],
        "cf": [
            {
                "label": "Net income (loss)",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": 303262000
            },
            {
                "label": "Less accumulated depreciation",
                "concept": "Depreciation",
                "unit": "usd",
                "value": 12540000
            },
            {
                "label": "Amortization of patents",
                "concept": "AmortizationOfIntangibleAssets",
                "unit": "usd",
                "value": 1912000
            },
            {
                "label": "Amortization of premium (discount) on investments, net",
                "concept": "AccretionAmortizationOfDiscountsAndPremiumsInvestments",
                "unit": "usd",
                "value": 7485000
            },
            {
                "label": "Amortization of debt discount and debt issuance costs",
                "concept": "AmortizationOfFinancingCosts",
                "unit": "usd",
                "value": 1942000
            },
            {
                "label": "Amortization of convertible senior notes discount",
                "concept": "AmortizationOfDebtDiscountPremium",
                "unit": "usd",
                "value": 37338000
            },
            {
                "label": "Amortization of long-term financing liability for leased facility",
                "concept": "AmortizationOfLeasedAsset",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Stock-based compensation expense",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 146574000
            },
            {
                "label": "Gain on investment in Regulus Therapeutics, Inc.",
                "concept": "GainOnSaleOfInvestments",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Loss on early retirement of debt",
                "concept": "GainsLossesOnExtinguishmentOfDebt",
                "unit": "usd",
                "value": -21865000
            },
            {
                "label": "Deferred income taxes (including benefit from valuation allowance release)",
                "concept": "DeferredIncomeTaxesAndTaxCredits",
                "unit": "usd",
                "value": -7096000
            },
            {
                "label": "Contracts receivable",
                "concept": "IncreaseDecreaseInContractWithCustomerAsset",
                "unit": "usd",
                "value": 47674000
            },
            {
                "label": "Inventories",
                "concept": "IncreaseDecreaseInInventories",
                "unit": "usd",
                "value": 5411000
            },
            {
                "label": "Other current and long-term assets",
                "concept": "IncreaseDecreaseInOtherOperatingAssets",
                "unit": "usd",
                "value": 44659000
            },
            {
                "label": "Long-term income tax receivable",
                "concept": "IncreaseDecreaseInIncomeTaxesReceivable",
                "unit": "usd",
                "value": -8418000
            },
            {
                "label": "Accounts payable",
                "concept": "IncreaseDecreaseInAccountsPayable",
                "unit": "usd",
                "value": -16343000
            },
            {
                "label": "Income taxes",
                "concept": "IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable",
                "unit": "usd",
                "value": 31656000
            },
            {
                "label": "Accrued compensation",
                "concept": "IncreaseDecreaseInOtherEmployeeRelatedLiabilities",
                "unit": "usd",
                "value": 8089000
            },
            {
                "label": "Deferred contract revenue",
                "concept": "IncreaseDecreaseInContractWithCustomerLiability",
                "unit": "usd",
                "value": -119283000
            },
            {
                "label": "Net cash provided by operating activities",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": 345720000
            },
            {
                "label": "Purchases of short-term investments",
                "concept": "PaymentsToAcquireAvailableForSaleSecuritiesDebt",
                "unit": "usd",
                "value": 1946726000
            },
            {
                "label": "Proceeds from sale of short-term investments",
                "concept": "ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities",
                "unit": "usd",
                "value": 1951734000
            },
            {
                "label": "Purchases of property, plant and equipment",
                "concept": "PaymentsToAcquirePropertyPlantAndEquipment",
                "unit": "usd",
                "value": 30905000
            },
            {
                "label": "Proceeds from the sale of Regulus Therapeutics, Inc.",
                "concept": "ProceedsFromSaleOfEquityMethodInvestments",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Net cash (used in) provided by investing activities",
                "concept": "NetCashProvidedByUsedInInvestingActivities",
                "unit": "usd",
                "value": -41274000
            },
            {
                "label": "Net proceeds from stock option exercises, vesting of restricted stock units, and ESPP purchases",
                "concept": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions",
                "unit": "usd",
                "value": 119657000
            },
            {
                "label": "Payments of tax withholdings related to vesting of employee stock awards and exercise of employee stock options",
                "concept": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
                "unit": "usd",
                "value": 19242000
            },
            {
                "label": "Proceeds from the issuance of 0.125 percent convertible senior notes",
                "concept": "ProceedsFromConvertibleDebt",
                "unit": "usd",
                "value": 109500000
            },
            {
                "label": "0.125 percent convertible senior notes issuance costs",
                "concept": "PaymentsOfDebtIssuanceCosts",
                "unit": "usd",
                "value": 10428000
            },
            {
                "label": "Proceeds from issuance of warrants",
                "concept": "ProceedsFromIssuanceOfWarrants",
                "unit": "usd",
                "value": 56110000
            },
            {
                "label": "Purchase of note hedges",
                "concept": "PaymentsForHedgeFinancingActivities",
                "unit": "usd",
                "value": 108684000
            },
            {
                "label": "Repurchases and retirements of common stock",
                "concept": "PaymentsForRepurchaseOfCommonStock",
                "unit": "usd",
                "value": 34392000
            },
            {
                "label": "Principal payments on debt and capital lease obligations",
                "concept": "RepaymentsOfLongTermDebtAndCapitalSecurities",
                "unit": "usd",
                "value": 12500000
            },
            {
                "label": "Proceeds from issuance of common stock in Akcea Therapeutics, Inc. from its initial public offering, net of underwriters' discount",
                "concept": "ProceedsFromIssuanceInitialPublicOffering",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Proceeds from building mortgage debt, net of issuance costs",
                "concept": "ProceedsFromDebtNetOfIssuanceCosts",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Proceeds from the sale of Akcea Therapeutics, Inc. common stock to Novartis in a private placement",
                "concept": "ProceedsFromIssuanceOfPrivatePlacement",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Offering costs paid",
                "concept": "PaymentsOfStockIssuanceCosts",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Net cash provided by financing activities",
                "concept": "NetCashProvidedByUsedInFinancingActivities",
                "unit": "usd",
                "value": 100021000
            },
            {
                "label": "Net increase in cash and cash equivalents",
                "concept": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
                "unit": "usd",
                "value": 404467000
            },
            {
                "label": "Interest paid",
                "concept": "InterestPaidNet",
                "unit": "usd",
                "value": 9870000
            },
            {
                "label": "Income taxes paid",
                "concept": "IncomeTaxesPaidNet",
                "unit": "usd",
                "value": 9041000
            },
            {
                "label": "Right-of-use assets obtained in exchange for lease liabilities",
                "concept": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
                "unit": "usd",
                "value": 14178000
            },
            {
                "label": "Purchases of property, plant and equipment included in long-term obligations",
                "concept": "CapitalExpendituresIncurredButNotYetPaid",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "0.125 percent convertible senior notes principal issued related to our December 2019 debt exchange/issuance",
                "concept": "NotesIssued1",
                "unit": "usd",
                "value": 439326000
            },
            {
                "label": "1 percent convertible senior notes principal extinguished related to our December 2019 debt exchange",
                "concept": "NotesReduction",
                "unit": "usd",
                "value": 375590000
            }
        ],
        "ic": [
            {
                "label": "Revenue",
                "concept": "RevenueFromContractWithCustomerExcludingAssessedTax",
                "unit": "usd",
                "value": 1122599000
            },
            {
                "label": "Cost of Products Sold [Abstract]",
                "concept": "CostOfGoodsAndServicesSold",
                "unit": "usd",
                "value": 4384000
            },
            {
                "label": "Selling, General and Administrative [Member]",
                "concept": "SellingGeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 286644000
            },
            {
                "label": "Total operating expenses",
                "concept": "CostsAndExpenses",
                "unit": "usd",
                "value": 756716000
            },
            {
                "label": "Income (loss) from operations",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": 365883000
            },
            {
                "label": "Investment income",
                "concept": "InvestmentIncomeNet",
                "unit": "usd",
                "value": 52205000
            },
            {
                "label": "Interest expense",
                "concept": "InterestExpense",
                "unit": "usd",
                "value": 48768000
            },
            {
                "label": "Loss on early retirement of debt",
                "concept": "GainsLossesOnExtinguishmentOfDebt",
                "unit": "usd",
                "value": -21865000
            },
            {
                "label": "Other expenses",
                "concept": "OtherNonoperatingIncomeExpense",
                "unit": "usd",
                "value": -686000
            },
            {
                "label": "Income (loss) before income tax benefit (expense)",
                "concept": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
                "unit": "usd",
                "value": 346769000
            },
            {
                "label": "Total current income tax expense (benefit)",
                "concept": "IncomeTaxExpenseBenefit",
                "unit": "usd",
                "value": 43507000
            },
            {
                "label": "Net income (loss)",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": 303262000
            },
            {
                "label": "Net (income) loss attributable to noncontrolling interest in Akcea Therapeutics, Inc.",
                "concept": "NetIncomeLossAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 9116000
            },
            {
                "label": "Adjustments to reconcile net income (loss) to net cash provided by operating activities",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": 294146000
            },
            {
                "label": "Basic net income per share (in dollars per share)",
                "concept": "EarningsPerShareBasic",
                "unit": "usd/shares",
                "value": 2.12
            },
            {
                "label": "Shares used in computing basic net income per share (in shares)",
                "concept": "WeightedAverageNumberOfSharesOutstandingBasic",
                "unit": "shares",
                "value": 139998000
            },
            {
                "label": "Diluted net income per share (in dollars per share)",
                "concept": "EarningsPerShareDiluted",
                "unit": "usd/shares",
                "value": 2.08
            },
            {
                "label": "Shares used in computing diluted net income per share (in shares)",
                "concept": "WeightedAverageNumberOfDilutedSharesOutstanding",
                "unit": "shares",
                "value": 142872000
            },
            {
                "label": "Unrealized gains (losses) on investments, net of tax",
                "concept": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
                "unit": "usd",
                "value": 6633000
            },
            {
                "label": "Reclassification adjustment for realized gains included in net income (loss)",
                "concept": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Currency translation adjustment",
                "concept": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax",
                "unit": "usd",
                "value": 93000
            },
            {
                "label": "Comprehensive income (loss)",
                "concept": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 309988000
            },
            {
                "label": "Comprehensive income (loss) attributable to noncontrolling interest in Akcea Therapeutics, Inc.",
                "concept": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 9118000
            },
            {
                "label": "Comprehensive income (loss) attributable to Ionis Pharmaceuticals, Inc. common stockholders",
                "concept": "ComprehensiveIncomeNetOfTax",
                "unit": "usd",
                "value": 300870000
            }
        ]
    }
}